-       Report 
   - January 2024
    -  200 Pages 
    Global
   
   From       €3724EUR$4,150USD£3,268GBP 
                  -       Report 
   - July 2024
    -  100 Pages 
    Global
   
   From       €2692EUR$3,000USD£2,363GBP 
      €3365EUR$3,750USD£2,953GBP 
                  -       Report 
   - July 2024
    -  150 Pages 
    Global
   
   From       €2692EUR$3,000USD£2,363GBP 
      €3365EUR$3,750USD£2,953GBP 
                  -       Report 
   - July 2024
    -  150 Pages 
    Global
   
   From       €2692EUR$3,000USD£2,363GBP 
      €3365EUR$3,750USD£2,953GBP 
                  -       Report 
   - July 2024
    -  150 Pages 
    Global
   
   From       €2692EUR$3,000USD£2,363GBP 
      €3365EUR$3,750USD£2,953GBP 
                   -       Report 
   - July 2024
    -  100 Pages 
    Global
   
   From       €2692EUR$3,000USD£2,363GBP 
      €3365EUR$3,750USD£2,953GBP 
                -       Report 
   - July 2024
    -  115 Pages 
    Asia Pacific
   
   From       €4262EUR$4,750USD£3,741GBP 
                -       Report 
   - July 2024
    -  110 Pages 
    
   From       €4262EUR$4,750USD£3,741GBP 
                -       Report 
   - July 2024
    -  120 Pages 
    Global
   
   From       €4262EUR$4,750USD£3,741GBP 
                -       Report 
   - February 2024
    -  114 Pages 
    Global
   
   From       €4262EUR$4,750USD£3,741GBP 
                -       Report 
   - February 2024
    -  115 Pages 
    Global
   
   From       €4262EUR$4,750USD£3,741GBP 
                -       Report 
   - February 2024
    -  130 Pages 
    Global
   
   From       €4262EUR$4,750USD£3,741GBP 
                -       Report 
   - August 2023
    -  70 Pages 
    Latin America
   
   From       €4262EUR$4,750USD£3,741GBP 
                -       Report 
   - April 2023
    -  120 Pages 
    Global
   
   From       €4262EUR$4,750USD£3,741GBP 
                -       Report 
   - April 2023
    -  113 Pages 
    Global
   
   From       €4262EUR$4,750USD£3,741GBP 
                -       Report 
   - August 2022
    -  115 Pages 
    Global
   
   From       €4262EUR$4,750USD£3,741GBP 
                -       Report 
   - February 2024
    -  114 Pages 
    Global
   
   From       €4262EUR$4,750USD£3,741GBP 
                -       Report 
   - December 2024
    -  80 Pages 
    India
   
   From       €3141EUR$3,500USD£2,756GBP 
                -       Report 
   - February 2024
    -  186 Pages 
    Global
   
   From       €4038EUR$4,500USD£3,544GBP 
                From       €3141EUR$3,500USD£2,756GBP 
             
         Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is    estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less   Read more